Financial Ratios

SURYA PHARMACEUTICAL LTD.

NSE : NABSE : 532516ISIN CODE : INE249G01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.160 (0 %)
PREV CLOSE ( ) 0.16
OPEN PRICE ( ) 0.16
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.16 (749508)
VOLUME 234695
TODAY'S LOW / HIGH ( )0.16 0.16
52 WK LOW / HIGH ( ) 0.160.16
NSE
This Company is not listed in NSE
Select year
ParticularsMar2013Mar2012Mar2011Mar2010Mar2009
Operational & Financial Ratios
   Earnings Per Share (Rs)-14.89-13.475.2052.5738.79
   CEPS(Rs)-11.80-11.766.576.684.99
   DPS(Rs)0.000.000.151.501.20
   Book NAV/Share(Rs)-2.6812.2126.63208.13158.46
   Tax Rate(%)34.2030.5323.9615.9212.43
Margin Ratios
   Core EBITDA Margin(%)-266.57-11.1916.0714.0715.51
   EBIT Margin(%)-389.67-13.0114.6613.2014.01
   Pre Tax Margin(%)-709.84-23.838.067.828.53
   PAT Margin (%)-467.04-16.556.136.577.47
   Cash Profit Margin (%)-370.38-14.467.768.359.60
Performance Ratios
   ROA(%)-15.89-13.035.646.517.15
   ROE(%)-312.51-71.8024.5928.6827.57
   ROCE(%)-12.73-10.8416.1217.5717.17
   Asset Turnover(x)0.030.790.920.990.96
   Sales/Fixed Asset(x)0.072.373.933.913.08
   Working Capital/Sales(x)-0.08-3.548.451.971.70
Efficiency Ratios
   Fixed Capital/Sales(x)13.570.420.250.260.33
   Receivable days1302.5358.2949.6045.7853.56
   Inventory Days4068.63204.93189.72162.46148.15
   Payable days75.2212.7349.2490.4987.75
Valuation Parameters
   PER(x)0.000.004.710.340.14
   PCE(x)-0.10-0.923.732.651.07
   Price/Book(x)-0.430.890.920.850.34
   Yield(%)0.000.000.610.852.25
   EV/Net Sales(x)33.571.211.190.830.79
   EV/Core EBITDA(x)-11.81-10.907.135.464.70
   EV/EBIT(x)-8.04-9.157.936.195.41
   EV/CE(x)1.140.970.880.680.60
   M Cap / Sales0.390.140.300.230.11
Growth Ratio
   Net Sales Growth(%)-96.281.4141.1156.8848.59
   Core EBITDA Growth(%)4.81-167.6953.4342.9332.44
   EBIT Growth(%)-17.29-189.6556.7045.1928.00
   PAT Growth(%)-10.49-372.7231.6835.5134.56
   EPS Growth(%)-10.49-359.27-90.1235.5134.56
Financial Stability Ratios
   Total Debt/Equity(x)-36.987.092.812.352.18
   Current Ratio(x)0.540.721.152.633.17
   Quick Ratio(x)0.190.220.360.811.34
   Interest Cover(x)-1.22-1.202.222.452.56
   Total Debt/Mcap(x)86.178.003.052.766.48

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.